Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning
Avichai Shimoni; Luca Vago; Massimo Bernardi; Ronit Yerushalmi; Jacopo Peccatori; Raffaella Greco; Noga Shem‐Tov; Alessandro Lo Russo; Ivetta Danylesko; Arie Apel; Chiara Bonini; Maria Teresa Lupo Stanghellini; Arnon Nagler; Fabio Ciceri
Author Information: Division of Hematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.